How much funding has Ark Biotech raised?

Ark Biotech has raised $9.5M in total funding, most recently a Series A round.

Who are Ark Biotech's investors?

Ark Biotech's investors include 14W, 20VC, Adjacent, Astanor Ventures.

When was Ark Biotech founded?

Ark Biotech was founded in 2021.

Where is Ark Biotech headquartered?

Ark Biotech is headquartered in Boston, Massachusetts, United States.

What industry is Ark Biotech in?

Ark Biotech operates in Biotech, SaaS.

How many employees does Ark Biotech have?

Ark Biotech has 11-50 employees.

Ark Biotech

Boston, United States · Founded 2021 · $9.5M raised

Biotech

SaaS

Headquarters: Boston, Massachusetts
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: ark.bio
Total Funding: $9.5M
Last Round: $6.5M Series ADec 2021
Rounds: 2

About

Ark Biotech is a bioprocess software company that provides an intelligent platform for cell manufacturing process development and optimization. Founded in 2021 and headquartered in Boston, Massachusetts, Ark builds virtual bioreactor simulation tools and AI-powered copilot software that help biotech and cultivated food companies accelerate development timelines and make better decisions from early-stage process development through commercial-scale manufacturing. The platform replaces costly physical experiments with high-fidelity computational models, enabling faster scale-up and reduced manufacturing risk.

Summary

Ark Biotech is a Biotech company based in Boston, United States, founded in 2021. It has raised $9.5M in total across 2 rounds, most recently a $6.5M Series A round in Dec 2021. Investors include 14W, 20VC and Adjacent.